Podcast Powered by CENTOGENE

Prof. Peter Bauer, M.D., is passionate about turning medical questions into complete and fast analytical processes – ensuring that medically-driven results are brought to clinicians and patients immediately. He received his board certification in Human Genetics in 2006 and previously headed the Molecular Diagnostic Laboratory at the Institute of Medical Genetics and Applied Genomics at the University Hospital Tübingen. Peter has authored more than 250 publications in Neurogenetics, Oncogenetics, Cardiogenetics, and Sequencing Technology. He currently serves as CENTOGENE's Chief Medical & Genomic Officer.

Jorge serves as CENTOGENE’s Vice President Medical Genetics. Bringing in over 15 years of leadership experience, he is responsible for overseeing policies, management, and regulations to drive clinical and operational value. Before joining CENTOGENE, Jorge served as the Director of the Molecular Diagnostics and Genomics Labs at CGC Genetics. He holds a medical degree from the University of Porto and is specialized in Rare Disease Genetics, Neurogenetics, Dysmorphology, and Molecular Genetics.

Dr. Christine Klein is a Professor of Neurology and Neurogenetics. Christine’s pursuit of knowledge has taken her all over the world, including Germany, the U.K., Sweden, France, Belarus, the U.S., Canada, and Australia. She completed her neurology training at Lubeck University in 2004 and was appointed Lichtenberg Professor at the Department of Neurology there in 2005. In 2009, she was appointed as the university’s Schilling Professor of Clinical and Molecular Neurogenetics and later the Director of its Institute of Neurogenetics in 2013. Christine has authored over 500 scientific papers, with more than 45,000 citations – as well as serving as Deputy Editor of Movement Disorders and Science Advances and previously as Associate Editor of Annals of Neurology.

She was Chair of the Congress Scientific Program Committee of the International Parkinson and Movement Disorder Society and President of the German Neurological Society and currently acts as Chair-Elect of the European Section of the International Parkinson and Movement Disorder Society, Lead of the Monogenic Network of the Global Parkinson’s Genetics Program, and an elected member of the National Academy of Sciences Leopoldina. Dr. Klein has also advised CENTOGENE from time to time as an expert consultant for our work with rare and neurodegenerative diseases.

Dr. Katrin Hahn is a renowned Neurologist and Senior Physician at Charité - Berlin University of Medicine – specializing in rare diseases, particularly amyloidosis, as well as polyneuropathy. With unparalleled expertise in these fields, Dr. Hahn serves as the Head of the Hereditary Neuropathies and Amyloidosis Research Group and the Neuro-AIDS Research Group at Charité. She is a member of several prestigious societies, including the International Federation of Clinical Neurophysiology and International Society of Amyloidosis, and her passion for research has led her to be published in several top tier journals – unlocking novel insights into a range of diseases, with an increased focus on hereditary transthyretin amyloidosis, otherwise known as ATTR.

Taylor Kane has spent most of her life as a rare disease advocate. She currently serves as Community Engagement Manager at AllStripes, a healthcare technology company dedicated to uncovering new treatments for people with rare diseases.In addition, she is the founder and executive director of Remember The Girls, an international non-profit organization that unites, educates and empowers female carriers of X-linked genetic disorders. Taylor’s activism began when she was in grade school, shortly after her father died from the rare X-linked disorder Adrenoleukodystrophy (ALD) and she learned that she was a carrier of this devastating disease. Not only did Taylor help raise substantial money for ALD research, she successfully lobbied the New Jersey legislature and Governor to enact a law requiring the screening of newborns for ALD in New Jersey. At the age of fourteen, Taylor founded a campaign called YAC (Young ALD Carriers) to support young females who carry the gene for ALD and to assist them in effectuating positive change through advocacy, social media, and the legislative process. Since college, she has served as a leader of the Young Adult Representatives of the Rare Disease Legislative Advocates (YARR), educating young adults with rare diseases to advocate for more affordable, safe, and effective treatments. Taylor is a summa cum laude graduate of The George Washington University who resides in New Jersey, but spends several months each year in the United Kingdom. She is an award-winning activist, an accomplished speaker, and a respected author, having recently published a memoir, Rare Like Us: From Losing My Dad to Finding Myself in a Family Plagued by Genetic Disease.